intramuscular injections

A multicenter research team has used gene therapy to improve muscle function in a single study participant with hereditary inclusion-body myositis  

posted on May 21, 2010 - 9:25am
Scientists at five U.S. institutions have successfully used gene therapy to improve muscle function in a single human subject with a hereditary form of inclusion-body myositis (IBM) caused by mutations of the GNE gene. Study results were published online March 30, in the Journal of Gene Medicine.

New content is being added every day. Please check back again.